Under construction – not a live service
Sign in
Not yet taking people in CanadaNo phase

Designing and Implementing a Safety Net Surveillance Program for High Risk CKD

Key facts

Where
Winnipeg, CanadaSee the site

Where in Canada

  • University of ManitobaWinnipeg, CanadaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Manitoba
Trial code
NCT07724288
Record updated
17 August 2026
Original description
The objective of this initiative is to develop and evaluate a risk-based, provincial public health screening program for chronic kidney disease (CKD) that provides proactive care for adults at high-risk of kidney failure who have not previously been referred to a nephrologist, through risk stratification, triage, education, and follow-up.Read full original descriptionShow less

Designing and Implementing a Safety Net Surveillance Program for High Risk CKD (CKD Safety Net)

The objective of this initiative is to develop and evaluate a risk-based, provincial public health screening program for chronic kidney disease (CKD) that provides proactive care for adults at high-risk of kidney failure who have not previously been referred to a nephrologist, through risk stratification, triage, education, and follow-up.

Overall, we aim to demonstrate that an integrated risk-based provincial public health screening program for CKD is feasible, and improves identification of high-risk individuals, subsequently creating a model of care that can be adopted by other jurisdictions.

Inclusion: Age > 18 years old; Resident of Manitoba / has Manitoba Health coverage; Either:; 2 eGFR <15 mL/min/1.73m2 tests within a 2-year timeframe or; A greater than 10% 2-year kidney failure risk (at 2 separate timepoints within a 2-year timeframe) - using the 4-variable or 3-variable 2-year Kidney Failure Risk Equation (KFRE).

Exclusion: A previous billing claim from a nephrologist; Receiving palliative care within 3 months of randomization; Previous history of dialysis and/or kidney transplantation.

ClinicalTrials.gov NCT07724288